Amneal Pharmaceuticals, Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||||||
| – | – | – | 14.5 | 11.4 | 12.6 | – | – | – | – | – | – | – | – | – | 9.3 | 7.5 | – | 84.0 | 56.7 | 67.5 | 357.3 | – | – | – | – | – | 65.0 | – | – | – | – | – | – | 773.7 | 550.4 | 56.8 | 33.4 | 36.1 | |
| – | – | – | 2.2 | 1.9 | 2.1 | 1.7 | 2.0 | 1.0 | 1.0 | 0.5 | 0.2 | 0.4 | 0.3 | 0.4 | 0.3 | 0.3 | 0.5 | 0.4 | 0.4 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.6 | 0.8 | 0.8 | 1.0 | 0.9 | 1.0 | 0.9 | 1.1 | 1.4 | 1.3 | 1.8 | |
| – | – | – | – | – | 223,975,367.9 | 4.2 | 5.7 | 1.9 | 3.8 | 2.0 | 1.0 | 2.9 | 1.6 | 2.3 | 1.9 | 2.2 | 3.1 | 2.2 | 2.3 | 2.0 | 1.6 | 1.7 | 1.0 | 1.0 | 0.7 | 1.5 | 2.0 | 75.2 | – | – | – | – | – | – | – | – | – | 171.9 | |
| – | – | – | 2.3 | 3.2 | 3.4 | 3.9 | 3.8 | 2.5 | 2.4 | 1.9 | 1.6 | 2.0 | 1.9 | 1.9 | 1.6 | 1.6 | 1.7 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.4 | 1.3 | 1.2 | 1.4 | 1.4 | 1.7 | 1.8 | 1.8 | 1.9 | 1.7 | 1.8 | 1.8 | 1.9 | 2.1 | 2.1 | 2.6 | |
| – | – | – | 8.8 | 11.7 | 11.6 | 52.4 | 37.5 | 38.3 | – | 17.5 | 14.5 | 20.5 | 10.6 | 9.6 | 10.6 | 9.1 | 9.8 | 8.4 | 7.8 | 8.0 | 8.3 | 27.6 | 22.7 | 19.8 | 16.8 | 7.1 | 7.0 | 10.1 | 12.9 | 13.2 | 14.0 | 11.0 | 9.4 | 8.6 | 10.1 | 10.5 | 10.2 | 12.6 | |
| – | – | – | 27.6 | 16.0 | 27.1 | – | – | 11.2 | 94.4 | 9.5 | 1.9 | – | 7.3 | 2.5 | 3.1 | 2.1 | 2.5 | 4.3 | 3.5 | 3.7 | 5.1 | 12.1 | 6.9 | – | 8.0 | 3.3 | 4.9 | 5.4 | 15.1 | 11.5 | 11.2 | 11.1 | 11.6 | 9.9 | 13.3 | 17.3 | 19.9 | 68.3 | |
| – | – | – | 3.6% | 6.3% | 3.7% | -1.5% | -1.6% | 8.9% | 1.1% | 10.6% | 52.6% | -14.1% | 13.8% | 39.9% | 32.2% | 46.5% | 40.7% | 23.4% | 28.3% | 27.0% | 19.5% | 8.2% | 14.6% | -11.8% | 12.5% | 30.3% | 20.5% | 18.6% | 6.6% | 8.7% | 8.9% | 9.0% | 8.6% | 10.1% | 7.5% | 5.8% | 5.0% | 1.5% | |
| Margins | |||||||||||||||||||||||||||||||||||||||
| – | – | – | 52.5% | 50.3% | 51.2% | 49.3% | 46.2% | 43.1% | 35.7% | 31.9% | 25.3% | 21.7% | 27.0% | 28.3% | 30.4% | 31.5% | 32.0% | 34.3% | 37.2% | 36.7% | 35.8% | 34.9% | 34.4% | 35.5% | 34.7% | 34.9% | 35.5% | 35.8% | 36.7% | 36.4% | 36.7% | 36.5% | 36.7% | 37.7% | 36.8% | 36.9% | 38.7% | 39.3% | |
| – | – | – | 24.9% | 23.7% | 24.6% | 3.3% | 2.5% | -1.2% | -9.7% | -0.8% | -11.7% | -15.3% | -5.8% | -3.8% | 2.5% | 4.6% | 4.0% | 6.6% | 7.8% | 7.3% | 6.2% | -6.4% | -5.6% | -4.3% | -3.7% | 8.4% | 9.5% | 8.5% | 6.4% | 6.7% | 7.0% | 8.9% | 12.7% | 13.2% | 9.8% | 10.8% | 12.1% | 12.9% | |
| – | – | – | 15.4% | 16.3% | 16.4% | -6.4% | -6.8% | -10.2% | -14.7% | -3.6% | -19.6% | -22.3% | -11.9% | -11.2% | 3.3% | 4.6% | -0.9% | 0.4% | 0.7% | 0.5% | 0.1% | -6.3% | -6.2% | -5.9% | -5.9% | -0.1% | 0.4% | -3.5% | -6.8% | -6.7% | -6.9% | -4.2% | -0.5% | 0.1% | 0.2% | 2.4% | 4.0% | 5.0% | |
| – | – | – | 8.1% | 11.6% | 7.6% | -2.6% | -3.1% | 9.2% | 1.0% | 5.3% | 11.6% | -5.9% | 4.2% | 16.2% | 9.9% | 15.9% | 20.7% | 8.8% | 10.8% | 9.2% | 5.8% | 1.9% | 2.1% | -1.6% | 1.2% | 6.3% | 5.8% | 11.5% | 5.0% | 6.8% | 8.6% | 7.9% | 8.3% | 9.2% | 8.3% | 7.8% | 6.7% | 2.7% | |
| Returns | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | 1,773,300,000.0% | -16.1% | -19.8% | -18.9% | -57.0% | -14.5% | -85.6% | -156.0% | -62.5% | -63.4% | 20.6% | 30.0% | -5.4% | 2.7% | 4.0% | 2.9% | 0.5% | -47.7% | -44.4% | -43.6% | -45.8% | -0.6% | 3.1% | -424.6% | – | – | – | – | – | – | – | – | – | 476.5% | |
| – | – | – | 12.9% | 12.5% | 13.1% | -1.8% | -2.2% | -3.9% | -6.1% | -1.6% | -9.1% | -9.9% | -4.5% | -4.8% | 1.5% | 2.3% | -0.4% | 0.2% | 0.4% | 0.3% | 0.0% | -3.3% | -3.4% | -3.4% | -3.7% | -0.1% | 0.3% | -2.4% | -4.9% | -5.0% | -5.3% | -3.3% | -0.4% | 0.1% | 0.2% | 2.0% | 3.4% | 4.2% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||||||
| 2,330 | 1,229 | – | 45 | 1,411 | 1,433 | 2,679 | 2,710 | 2,439 | 2,599 | 2,603 | 2,440 | 2,495 | 2,749 | 2,581 | 2,522 | 2,451 | 2,318 | 2,523 | 2,430 | 2,478 | 2,509 | 2,700 | 2,626 | 2,671 | 2,602 | 2,647 | 2,618 | 2,564 | 2,600 | 2,585 | 2,477 | 2,391 | 2,432 | 2,401 | 2,387 | 2,276 | 2,389 | 2,558 | |
| – | – | – | 0.2 | 5.0 | 4.5 | 29.5 | 18.3 | 22.4 | – | 12.9 | 12.5 | 16.1 | 8.9 | 7.5 | 8.6 | 7.1 | 6.8 | 6.5 | 5.9 | 6.2 | 6.6 | 23.4 | 20.4 | 17.8 | 15.6 | 6.0 | 5.6 | 6.4 | 7.5 | 7.4 | 6.9 | 5.4 | 4.4 | 4.1 | 4.3 | 3.8 | 3.8 | 3.9 | |
| -15.2% | -15.2% | – | -35.2% | -28.7% | 0.0% | 10.9% | 10.9% | 20.6% | 10.8% | 10.8% | 10.7% | 6.3% | 7.3% | 7.5% | 7.5% | 7.6% | 8.2% | 8.6% | 8.8% | 9.1% | 10.1% | 6.9% | 7.7% | 7.9% | 8.1% | 8.6% | 9.0% | 0.6% | -1.8% | -1.6% | -2.7% | -3.1% | -3.9% | -3.3% | -3.0% | -1.9% | -1.3% | 0.9% | |
| – | – | – | – | – | 148,135,800.0 | 5.5 | 5.7 | 3.0 | 5.6 | 5.8 | 6.7 | 11.4 | 9.9 | 9.3 | 9.3 | 9.2 | 8.6 | 8.1 | 7.8 | 7.6 | 7.0 | 10.0 | 9.1 | 9.0 | 9.3 | 8.7 | 8.2 | 134.2 | – | – | – | – | – | – | – | – | – | 81.3 | |
| Per Share | |||||||||||||||||||||||||||||||||||||||
| – | – | – | 1.40 | 1.46 | 1.54 | -0.63 | -0.78 | -1.33 | -2.11 | -0.52 | -2.59 | -2.55 | -1.34 | -1.32 | 0.42 | 0.62 | -0.11 | 0.06 | 0.09 | 0.07 | 0.01 | -0.88 | -0.87 | -0.86 | -0.89 | -0.01 | 0.06 | -0.34 | -0.55 | -0.55 | -0.60 | -0.38 | -0.04 | 0.01 | 0.02 | 0.22 | 0.37 | 0.48 | |
| – | – | – | 9.04 | 9.00 | 9.43 | 9.73 | 11.38 | 13.06 | 14.36 | 14.25 | 13.21 | 11.47 | 11.35 | 11.80 | 12.74 | 13.50 | 13.14 | 13.54 | 13.84 | 14.02 | 14.00 | 14.06 | 14.13 | 14.60 | 14.94 | 14.93 | 14.94 | 9.82 | 8.12 | 8.15 | 8.66 | 9.02 | 8.74 | 8.85 | 9.04 | 9.29 | 9.26 | 9.50 | |
| -1.61 | -1.61 | – | -3.80 | -3.36 | 0.00 | 3.89 | 3.91 | 7.04 | 3.70 | 3.59 | 3.03 | 1.64 | 2.15 | 2.08 | 2.04 | 2.05 | 2.14 | 2.28 | 2.35 | 2.41 | 2.61 | 1.86 | 1.96 | 1.97 | 1.94 | 2.05 | 2.07 | 0.08 | -0.21 | -0.18 | -0.30 | -0.35 | -0.41 | -0.35 | -0.34 | -0.22 | -0.14 | 0.10 | |
| – | – | – | 0.74 | 1.04 | 0.72 | -0.25 | -0.36 | 1.20 | 0.15 | 0.76 | 1.53 | -0.67 | 0.48 | 1.92 | 1.26 | 2.14 | 2.72 | 1.19 | 1.50 | 1.30 | 0.82 | 0.26 | 0.29 | -0.24 | 0.17 | 0.94 | 0.86 | 1.13 | 0.40 | 0.55 | 0.74 | 0.71 | 0.72 | 0.81 | 0.75 | 0.73 | 0.62 | 0.25 | |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.